Fractal Therapeutics

Fractal Therapeutics is a strategic partner for drug discovery and development, using modeling to drive programs forward quickly and cost-effectively. At Fractal, modeling isn’t the deliverable – progress is. We use mathematical modeling as a decision-making tool to accelerate drug R&D rigorously and with purpose. We work collaboratively with partners to build preclinical and early-clinical pharmacology packages that answer critical-path questions efficiently. Depending on the client’s needs, that might mean helping identify assets for in-licensing, evaluating the feasibility of the target product profile, mapping the route to the next value inflection point, designing or managing studies, modeling results, or summarizing findings for regulatory and investor materials. Our team at Fractal is made up of seasoned drug developers who know how to use modeling to advance a drug quickly and efficiently. Our work couples mathematical modeling tightly with carefully designed animal studies and clinical trials. The goal: to help clients make the right decisions, while minimizing wasted time and cost. To learn more, visit or ping us on LinkedIn!